What are the 3 main types of long COVID?

Researchers were also able to begin identifying subspecies of SARS-CoV-2 and symptom clusters associated with vaccination.

Dr. Lianne S. KanasThe study’s corresponding author and postdoctoral fellow at King’s College London said: medical news today:

“Our results suggest that chest-related symptoms (respiratory clusters) in the UK population are more evident in unvaccinated patients infected with early forms of the virus. [referred to as the “wild” variant]”

“In contrast, patients with either alpha or delta mutations show a higher incidence of neurological symptoms such as olfactory disturbances and brain fog,” Dr. Canas continued. rice field.

“Unfortunately, we were unable to reliably assess the efficacy of vaccination against these two variants. We had a significant number of unvaccinated people who hadn’t had COVID for a long time,” she noted.

Systemic/inflammatory and abdominal conditions were weakly associated with all variants.

“On average, the virus wild-type shows a longer prevalence of symptoms, 30 weeks compared to delta and alpha of 24 and 25 weeks, respectively.”

“However, as we only analyzed data from individuals who had been ill for more than 12 weeks, these results were less important than cluster profiling, and further studies are needed that also consider the effects of vaccination.”

“The results of this study show that individuals suffering from prolonged COVID who experience severe shortness of breath, hoarseness, loss of sense of smell, fatigue, delirium, olfactory disturbances, headaches, and fever, [experience] Severe long-term symptoms. “

“Physicians armed with this information may be better able to counsel patients and their expectations for symptom improvement. We may work on a targeted therapeutic approach.”

The authors of this study are still analyzing data related to the Omicron subspecies, but share some early insights.

“Initial results show that the long-term prevalence of COVID in patients infected with the Omicron variant is much lower than that of other variants,” said Dr. Canas.

Articles on ZOE research The odds of getting a long COVID from Omicron are 20% to 50% less likely than other variants, with Omicron cases representing only 4.4% of cases studied, compared to 10.8% of Delta variant cases. .

Dr. Marathe cited other research into the relationship between Omicron variants and long-term COVID.

“Some studies have reported a lower risk of developing long-term COVID after COVID-19 infection with the Omicron variant compared to the delta variant, whereas other studies have reported a lower risk of developing long-term COVID after infection with the Omicron variant. This is also true for the overall reduction in severity of symptoms during acute infection with Omicron.”

A low percentage of people who get COVID-19 from Omicron variants develop long-term COVID, but the highly contagious strain means more people are infected and therefore more people are experiencing prolonged COVID.

“The total number of long-term COVID patients in our community may be low, but at Boston Medical Center, the number of patients seeking treatment in long-term COVID clinics has stabilized through post-Delta and post-Omicron surges. ‘ said Dr. . Marathi.

Not much has changed, she said, when it comes to lengthy COVID symptoms from recent variants:

“We did not find significant differences in long-term COVID symptoms between the Omicron variants prevalent in winter and spring. Fatigue, shortness of breath, mood disturbances and brain fog are still reported by long-term patients with COVID. It was the most common complaint made.

Dr. Marathe found the new research worthwhile.

“This may pave the way for additional research efforts to assess the different pathobiological pathways that may contribute to the development of COVID over time, and may help us better define the condition.” It’s helpful.”

“I think we still don’t know who is at risk of long-term COVID-19 and why they are at risk. It helps inform strategy,” she added.